Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Biomarker, Medicine, Dementia, Disease, Cerebrospinal fluid, and Alzheimer's disease.
Depressive Symptoms and Amyloid Pathology
The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts
Polygenic pathways shape white matter vulnerability to Alzheimer’s disease-related pathophysiological changes
Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies
Blood‐based multivariate methylation risk score for cognitive impairment and dementia
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD study
Comparing parametric methods for longitudinal measurement of β‐amyloid pathology with PET in elderly individuals
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer’s disease in the EMIF‐AD Multimodal Biomarker Discovery study
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels
World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia
Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics
Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
Inflammatory biomarkers in Alzheimer's disease plasma
A metabolite‐based machine learning approach to diagnose Alzheimer‐type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study
European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials
Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study
The Vascular Impairment of Cognition Classification Consensus Study
Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects
The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey